Filter Results:
(847)
Show Results For
- All HBS Web
(847)
- News (167)
- Research (586)
- Multimedia (13)
- Faculty Publications (383)
Show Results For
- All HBS Web
(847)
- News (167)
- Research (586)
- Multimedia (13)
- Faculty Publications (383)
- 27 Jul 2020
- Working Paper Summaries
Gender Inequality in Research Productivity During the COVID-19 Pandemic
Keywords: by Ruomeng Cui, Hao Ding, and Feng Zhu
- June 2021
- Article
From Predictions to Prescriptions: A Data-driven Response to COVID-19
By: Dimitris Bertsimas, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg and Cynthia Zeng
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at... View Details
Keywords: COVID-19; Health Pandemics; AI and Machine Learning; Forecasting and Prediction; Analytics and Data Science
Bertsimas, Dimitris, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg, and Cynthia Zeng. "From Predictions to Prescriptions: A Data-driven Response to COVID-19." Health Care Management Science 24, no. 2 (June 2021): 253–272.
- March 2022
- Article
Where to Locate COVID-19 Mass Vaccination Facilities?
By: Dimitris Bertsimas, Vassilis Digalakis Jr, Alexander Jacquillat, Michael Lingzhi Li and Alessandro Previero
The outbreak of COVID-19 led to a record-breaking race to develop a vaccine. However, the limited vaccine capacity creates another massive challenge: how to distribute vaccines to mitigate the near-end impact of the pandemic? In the United States in particular, the new... View Details
Keywords: Vaccines; COVID-19; Health Care and Treatment; Health Pandemics; Performance Effectiveness; Analytics and Data Science; Mathematical Methods
Bertsimas, Dimitris, Vassilis Digalakis Jr, Alexander Jacquillat, Michael Lingzhi Li, and Alessandro Previero. "Where to Locate COVID-19 Mass Vaccination Facilities?" Naval Research Logistics Quarterly 69, no. 2 (March 2022): 179–200.
- Article
Potentially Long-Lasting Effects of the Pandemic on Scientists
By: Jian Gao, Yian Yin, Kyle R. Myers, Karim R. Lakhani and Dashun Wang
Two surveys of principal investigators conducted between April 2020 and January 2021 reveal that while the COVID-19 pandemic’s initial impacts on scientists’ research time seem alleviated, there has been a decline in the rate of initiating new projects. This dimension... View Details
Gao, Jian, Yian Yin, Kyle R. Myers, Karim R. Lakhani, and Dashun Wang. "Potentially Long-Lasting Effects of the Pandemic on Scientists." Art. 6188. Nature Communications 12 (2021).
- December 2020
- Article
What Has Changed? The Impact of COVID Pandemic on the Technology and Innovation Management Research Agenda
By: Gerard George, Karim R. Lakhani and Phanish Puranam
Whereas the pandemic has tested the agility and resilience of organizations, it forces a deeper look at the assumptions underlying theoretical frameworks that guide managerial decisions and organizational practices. In this commentary, we explore the impact of the... View Details
George, Gerard, Karim R. Lakhani, and Phanish Puranam. "What Has Changed? The Impact of COVID Pandemic on the Technology and Innovation Management Research Agenda." Journal of Management Studies 57, no. 8 (December 2020).
- May 2022
- Article
Unprecedented Training: Experience of Residents During the COVID-19 Pandemic
By: Nicholas Stark, Tuna Cem Hayirli, Aditi Bhanja, Michaela J. Kerrissey, James Hardy and Christopher Peabody
Stark, Nicholas, Tuna Cem Hayirli, Aditi Bhanja, Michaela J. Kerrissey, James Hardy, and Christopher Peabody. "Unprecedented Training: Experience of Residents During the COVID-19 Pandemic." Annals of Emergency Medicine 79, no. 5 (May 2022): 488–494.
- September 17, 2020
- Article
Protecting Vulnerable Older Patients during the Pandemic
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
Older people (70 years and older) with multiple chronic conditions have the highest risk of being hospitalized and dying from COVID-19. The recent COVID-19 pandemic has highlighted how a strong primary care system can play an important role in protecting this group of... View Details
Keywords: COVID-19; High-risk Patients; Primary Care; Health Pandemics; Health Care and Treatment; Innovation and Invention; Demographics; Age
Ikram, Umar, Susanna Gallani, Jose F. Figueroa, and Thomas W. Feeley. "Protecting Vulnerable Older Patients during the Pandemic." NEJM Catalyst (September 17, 2020).
- 21 Jul 2020
- Working Paper Summaries
Business Reopening Decisions and Demand Forecasts During the COVID-19 Pandemic
- 2021
- Working Paper
Pandemic Schooling Mode and Student Test Scores: Evidence from U.S. States
By: Clare Halloran, Rebecca Jack, James C. Okun and Emily Oster
We estimate the impact of district-level schooling mode (in-person versus hybrid or distance learning) on test scores. We combine Spring 2021 state standardized test score data with comprehensive data on schooling in the 2020-21 school year across 12 states. We find... View Details
Keywords: COVID-19 Pandemic; In-person Schooling; Distance Learning; Outcomes Measurement; Health Pandemics; Education; Performance Evaluation
Halloran, Clare, Rebecca Jack, James C. Okun, and Emily Oster. "Pandemic Schooling Mode and Student Test Scores: Evidence from U.S. States." NBER Working Paper Series, No. 29497, November 2021.
- March 2022
- Teaching Note
The Coronavirus (COVID-19) Pandemic and the Global Economy (A) and (B)
By: Alberto Cavallo
Teaching Note for HBS Case Nos. 720-031 and 721-434. View Details
- Summer 2020
- Article
Is It Time to Rethink Globalized Supply Chains?: The COVID-19 Pandemic Should Be a Wake-up Call for Managers and Prompt Them to Consider Actions That Will Improve Their Resilience to Future Shocks
By: Willy C. Shih
The COVID-19 pandemic has exposed the complex interdependencies of globalized supply chains. While these global multistage production networks had spread during a relatively benign environment of falling trade barriers and increasing interdependencies among countries,... View Details
Keywords: Supply Chains; Pandemic; Resilience; Supply Chain Management; Supply Chain; Global Range; Health Pandemics; Disruption; System Shocks; Crisis Management; Manufacturing Industry; United States; Asia; Europe; China
Shih, Willy C. "Is It Time to Rethink Globalized Supply Chains? The COVID-19 Pandemic Should Be a Wake-up Call for Managers and Prompt Them to Consider Actions That Will Improve Their Resilience to Future Shocks." MIT Sloan Management Review 61, no. 4 (Summer 2020): 16–18.
- March 2021 (Revised August 2021)
- Supplement
Wendell Weeks at Corning Inc. (B): Valor Glass and the COVID-19 Pandemic
By: Ryan Raffaelli and Aldo Sesia
The (B) case offers a detailed account of Wendell Weeks’s innovation strategy at Corning, and how his approach played a critical role in the COVID-19 pandemic. It illustrates the company’s philosophy of making long-term investments in promising new technologies and... View Details
Keywords: Innovation and Invention; Innovation Strategy; Technological Innovation; Disruptive Innovation; Information Technology; Leadership; Health Pandemics; Technology Industry; United States; New York (city, NY)
Raffaelli, Ryan, and Aldo Sesia. "Wendell Weeks at Corning Inc. (B): Valor Glass and the COVID-19 Pandemic." Harvard Business School Supplement 421-078, March 2021. (Revised August 2021.)
- Winter 2022
- Article
Vaccines and the COVID-19 Pandemic: Lessons from Failure and Success
By: Scott Duke Kominers and Alex Tabarrok
The losses from the global COVID-19 pandemic have been staggering—trillions in economic costs, on top of significant losses of life, health, and well-being. The world made significant and successful investments in vaccines to mitigate the pandemic, yet there were... View Details
Keywords: COVID-19; Vaccination; Market Design; Health Pandemics; Loss; Outcome or Result; Opportunities; Crisis Management
Kominers, Scott Duke, and Alex Tabarrok. "Vaccines and the COVID-19 Pandemic: Lessons from Failure and Success." Oxford Review of Economic Policy 38, no. 4 (Winter 2022): 719–741.
- 2020
- Working Paper
Bankruptcy and the COVID-19 Crisis
By: Jialan Wang, Jeyul Yang, Benjamin Iverson and Raymond Kluender
We examine the impact of the COVID-19 economic crisis on business and consumer bankruptcies in the United States using real-time data on the universe of filings. Historically, bankruptcies have closely tracked the business cycle and contemporaneous unemployment rates.... View Details
Keywords: Bankruptcy; Financial Distress; COVID-19; Insolvency and Bankruptcy; Financial Crisis; Health Pandemics; United States
Wang, Jialan, Jeyul Yang, Benjamin Iverson, and Raymond Kluender. "Bankruptcy and the COVID-19 Crisis." Harvard Business School Working Paper, No. 21-041, September 2020.
- January 20, 2022
- Article
3 Steps to Help Companies Rebuild Trust During the Pandemic
By: Sandra J. Sucher and Shalene Gupta
Many workers feel battered and distrustful after almost two years of COVID-19 instability. But it's not too late for managers—even those who made damaging missteps—to repair these relationships, say Sandra Sucher and Shalene Gupta. View Details
Sucher, Sandra J., and Shalene Gupta. "3 Steps to Help Companies Rebuild Trust During the Pandemic." Harvard Business School Working Knowledge (January 20, 2022).
- 2022
- Working Paper
THEMIS: A Framework for Cost-Benefit Analysis of COVID-19 Non-Pharmaceutical Interventions
By: Dimitris Bertsimas, Michael Lingzhi Li and Saksham Soni
Since December 2019, the world has been ravaged by the COVID-19 pandemic, with over 150 million confirmed cases and 3 million confirmed deaths worldwide. To combat the spread of COVID-19, governments have issued unprecedented non-pharmaceutical interventions (NPIs),... View Details
Keywords: COVID-19; Health Pandemics; Policy; Framework; Cost vs Benefits; Outcome or Result; United States; Germany; Brazil; Singapore; Spain
Bertsimas, Dimitris, Michael Lingzhi Li, and Saksham Soni. "THEMIS: A Framework for Cost-Benefit Analysis of COVID-19 Non-Pharmaceutical Interventions." Working Paper, April 2022.
- September 8, 2020
- Article
Allocation of COVID-19 Relief Funding to Disproportionately Black Counties
By: Pragya Kakani, Amitabh Chandra and Sendhil Mullainathan
This study describes correlations between the dollar amount of relief funding authorized by the US Congress to fund prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level... View Details
Kakani, Pragya, Amitabh Chandra, and Sendhil Mullainathan. "Allocation of COVID-19 Relief Funding to Disproportionately Black Counties." JAMA, the Journal of the American Medical Association 324, no. 10 (September 8, 2020): 1000–1003.
- September 2020
- Supplement
China's Management of COVID-19 (B): Victory?
By: Meg Rithmire and Courtney Han
Rithmire, Meg, and Courtney Han. "China's Management of COVID-19 (B): Victory?" Harvard Business School Supplement 721-008, September 2020.